AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,523,619 | +104.1% | 196,090 | +154.3% | 0.21% | +97.2% |
Q2 2023 | $746,328 | +2285.0% | 77,100 | +2605.3% | 0.11% | +2040.0% |
Q1 2023 | $31,293 | -78.6% | 2,850 | -80.3% | 0.01% | -83.9% |
Q2 2022 | $146,000 | -46.3% | 14,480 | -3.4% | 0.03% | -29.5% |
Q4 2021 | $272,000 | -61.3% | 14,985 | -76.0% | 0.04% | -65.1% |
Q3 2021 | $703,000 | 0.0% | 62,492 | 0.0% | 0.13% | -0.8% |
Q2 2021 | $703,000 | -44.2% | 62,492 | -35.5% | 0.13% | -48.8% |
Q1 2021 | $1,259,000 | +181.0% | 96,961 | +199.5% | 0.25% | +166.7% |
Q4 2020 | $448,000 | – | 32,370 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 230,000 | $993,600 | 1.92% |
AlphaCentric Advisors LLC | 352,500 | $1,522,800 | 1.50% |
NEA Management Company, LLC | 3,969,834 | $17,149,683 | 0.96% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 573,530 | $2,477,650 | 0.76% |
ARMISTICE CAPITAL, LLC | 5,000,000 | $21,600,000 | 0.38% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 93,658 | $404,603 | 0.27% |
Artal Group S.A. | 1,000,000 | $4,320 | 0.24% |
Virtus ETF Advisers LLC | 64,786 | $279,876 | 0.15% |
TANG CAPITAL MANAGEMENT LLC | 200,000 | $864,000 | 0.13% |
HighMark Wealth Management LLC | 37,499 | $161,996 | 0.12% |